A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease

被引:8
|
作者
Joung, Jinwoon [1 ]
Oh, Jun Suk [1 ]
Yoon, Jung Min [1 ]
Ko, Kyung Ok [1 ]
Yoo, Gyeong Hee [2 ]
Cheon, Eun Jung [1 ]
机构
[1] Konyang Univ, Coll Med, Dept Pediat, Myunggok Med Res Ctr, 158 Gwanjeodong Ro, Daejeon 35365, South Korea
[2] Soonchunhyang Univ, Cheonan Hosp, Dept Pediat, Sonnchunhyang 6 Gil, Cheonan 31151, South Korea
关键词
Coronary artery dilatation; Decision tree model; IVIG resistance; Kawasaki disease; NATRIURETIC PEPTIDE; RISK-FACTORS; CHILDREN; ABNORMALITIES; YOUNG;
D O I
10.1186/s12887-022-03533-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives This study aims to develop a new algorithm for predicting intravenous immunoglobulin (IVIG) resistance and coronary artery involvement in Kawasaki disease (KD) through decision tree models. Methods Medical records of children hospitalized for KD were analysed retrospectively. We compared the clinical characteristics, and the laboratory data in the groups with IVIG resistance and coronary artery dilatations (CADs) in KD patients. The decision tree models were developed to predict IVIG resistance and CADs. Results A total 896 patients (511 males and 385 females; 1 month-12 years) were eligible. IVIG resistance was identified in 111 (12.3%) patients, and CADs were found in 156 (17.4%). Total bilirubin and nitrogen terminal- pro-brain natriuretic peptide (NT-proBNP) were significantly higher in IVIG resistant group than in IVIG responsive group (0.62 +/- 0.8 mg/dL vs 1.38 +/- 1.4 mg/dL and 1231 +/- 2136 pg/mL vs 2425 +/- 4459 mL, respectively, P < 0.01). Also, CADs were more developed in the resistant group (39/111; 14.9% vs. 117/785; 35.1%, P < 0.01). The decision tree for predicting IVIG resistance was classified based on total bilirubin (0.7 mg/mL, 1.46 mg/dL) and NT-proBNP (1561 pg/mL), consisting of two layers and four nodes, with 86.2% training accuracy and 90.5% evaluation accuracy. The Receiver Operating Characteristic (ROC) evaluated the predictive ability of the decision tree, and the area under the curve (AUC) (0.834; 95% confidence interval, 0.675-0.973; P < 0.05) showed relatively higher accuracy. The group with CADs had significantly higher total bilirubin and NT-proBNP levels than the control group (0.64 +/- 0.82 mg/dL vs 1.04 +/- 1.14 mg/dL and 1192 +/- 2049 pg/mL vs 2268 +/- 4136 pg/mL, respectively, P < 0.01). The decision trees for predicting CADs were classified into two nodes based on NT-proBNP (789 pg/mL) alone, with 83.5% training accuracy and 90.3% evaluation accuracy. Conclusion A new algorithm decision tree model presents for predicting IVIG resistance and CADs in KD, confirming the usefulness of NT-proBNP as a predictor of KD.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis
    Zheng, Xiaolan
    Li, Jinhui
    Yue, Peng
    Liu, Lei
    Li, Jiawen
    Zhou, Kaiyu
    Hua, Yimin
    Li, Yifei
    PLOS ONE, 2021, 16 (03):
  • [42] INTRAVENOUS IMMUNOGLOBULIN IN KAWASAKI DISEASE
    SALO, E
    PEDIATRIC RESEARCH, 1988, 24 (05) : 654 - 654
  • [43] RISK FACTORS OF INTRAVENOUS IMMUNOGLOBULIN RESISTANCE AND CORONARY ARTERIAL LESIONS IN TURKISH CHILDREN WITH KAWASAKI DISEASE
    Turkucar, Serkan
    Yildiz, Kaan
    Acari, Ceyhun
    Dundar, Hatice Adiguzel
    Kir, Mustafa
    Unsal, Erbil
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 439 - 440
  • [44] Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease
    Turkucar, Serkan
    Yildiz, Kaan
    Acari, Ceyhun
    Dundar, Hatice Adiguzel
    Kir, Mustafa
    Unsal, Erbil
    TURKISH JOURNAL OF PEDIATRICS, 2020, 62 (01) : 1 - 9
  • [45] Coronary Arterial Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Case-Control Study
    Santana Rojo, Virginia
    Silva Hernandez, Mariano
    Fernandez Fraga, Pablo
    Dorado Criado, Marta
    Fabra Garrido, Celia
    Castellano Damaso, Serafin
    Andrade Guerrero, Jose David
    Bautista Barea, Marta
    Barrios Machain, Ursino Adrian
    Deiros Bronte, Lucia
    Uceda Galiano, Angela
    Carton Sanchez, Antonio J.
    Labrandero de Lera, Carlos
    Garcia-Guereta Silva, Luis
    Ruiz Dominguez, Jose Antonio
    Bueno Barriocanal, Marta
    Molina Gutierrez, Miguel Angel
    Bret Zurita, Monserrat
    Gomez Zamora, Ana
    del Rio Garcia, Miguel
    Murias Loza, Sara
    Alonso Garcia, Luis Alfonso
    Escosa Garcia, Luis
    Baquero Artigao, Fernando
    Sainz Costa, Talia
    Ots Ruiz, Cristina
    Calvo Rey, Cristina
    Mendez Echevarria, Ana
    del Rosal Rabes, Teresa
    Aracil Santos, Francisco Javier
    EUROPEAN JOURNAL OF PEDIATRICS, 2019, 178 (11) : 1623 - 1623
  • [46] Predictors of Intravenous Immunoglobulin Resistance in Chinese Children with Kawasaki Disease
    Young, J. H. M.
    Huen, K. F.
    Chan, L. T. W.
    HONG KONG JOURNAL OF PAEDIATRICS, 2013, 18 (04) : 204 - 209
  • [47] Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
    Lu, Yaheng
    Chen, Tingting
    Wen, Yizhou
    Si, Feifei
    Wu, Xindan
    Yang, Yanfeng
    BMC PEDIATRICS, 2021, 21 (01)
  • [48] Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
    Yaheng Lu
    Tingting Chen
    Yizhou Wen
    Feifei Si
    Xindan Wu
    Yanfeng Yang
    BMC Pediatrics, 21
  • [49] Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study
    Son, Mary Beth
    Gauvreau, Kimberlee
    Burns, Jane C.
    Corinaldesi, Elena
    Tremoulet, Adriana H.
    Watson, Virginia E.
    Baker, Annette
    Fulton, David R.
    Sundel, Robert P.
    Newburger, Jane W.
    JOURNAL OF PEDIATRICS, 2011, 158 (04): : 644 - U157
  • [50] Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing
    Yang, Shuai
    Song, Ruixia
    Zhang, Junmei
    Li, Xiaohui
    Li, Caifeng
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 (03) : 262 - 267